➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Medtronic
Colorcon
Baxter
Harvard Business School

Last Updated: December 2, 2020

DrugPatentWatch Database Preview

CORTISONE ACETATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Cortisone Acetate patents expire, and what generic alternatives are available?

Cortisone Acetate is a drug marketed by Pharmacia And Upjohn, Watson Labs, Barr, Elkins Sinn, Everylife, Heather, Hikma Intl Pharms, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Lannett, Panray, Purepac Pharm, Vitarine, and Whiteworth Town Plsn. and is included in eighteen NDAs.

The generic ingredient in CORTISONE ACETATE is cortisone acetate. There are seventy-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cortisone acetate profile page.

US ANDA Litigation and Generic Entry Outlook for Cortisone Acetate

A generic version of CORTISONE ACETATE was approved as cortisone acetate by HIKMA INTL PHARMS on December 31st, 1969.

  Start Trial

Drug patent expirations by year for CORTISONE ACETATE
Recent Clinical Trials for CORTISONE ACETATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 2/Phase 3
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all CORTISONE ACETATE clinical trials

Pharmacology for CORTISONE ACETATE
Medical Subject Heading (MeSH) Categories for CORTISONE ACETATE

US Patents and Regulatory Information for CORTISONE ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CORTISONE ACETATE cortisone acetate INJECTABLE;INJECTION 008126-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CORTISONE ACETATE cortisone acetate TABLET;ORAL 008126-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Whiteworth Town Plsn CORTISONE ACETATE cortisone acetate TABLET;ORAL 080341-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Elkins Sinn CORTISONE ACETATE cortisone acetate TABLET;ORAL 080836-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs CORTISONE ACETATE cortisone acetate INJECTABLE;INJECTION 083147-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Inwood Labs CORTISONE ACETATE cortisone acetate TABLET;ORAL 080731-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CORTISONE ACETATE cortisone acetate TABLET;ORAL 008126-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Express Scripts
Colorcon
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.